HOMA-IR was developed by Matthews et al. at the University of Oxford in 1985 as a simple method to estimate insulin resistance from a single fasting blood sample measuring both glucose and insulin. The formula is: HOMA-IR equals fasting insulin in milliunits per litre multiplied by fasting glucose in mmol/L, divided by 22.5. The result estimates the relative insulin resistance of hepatic glucose production and peripheral glucose uptake compared to a theoretical normal reference subject. Despite its 1985 origins, it remains one of the most widely validated and cited metabolic research tools.
Interpreting the Result
In lean, healthy adults with no metabolic risk factors, HOMA-IR is typically below 1.0. Values between 1.5 and 2.5 indicate emerging insulin resistance; between 2.5 and 5.0 significant insulin resistance; above 5.0 severe insulin resistance consistent with metabolic syndrome. In the clinical context of type 2 diabetes development, HOMA-IR in the prediabetic range often precedes HbA1c elevation by 5 to 10 years, providing a window for intervention before irreversible beta-cell damage has occurred.
What Drives HOMA-IR Up
- Central obesity: visceral fat produces inflammatory cytokines that directly impair insulin receptor signalling
- Physical inactivity: skeletal muscle is the primary site of glucose disposal; inactive muscle expresses fewer GLUT-4 transporters
- Refined carbohydrate intake: repeated glycaemic spikes chronically elevate insulin requirements and gradually reduce receptor sensitivity
- Sleep deprivation: even a single night of sleep restriction measurably raises HOMA-IR the following morning
- Chronic stress: cortisol raises hepatic glucose output and reduces peripheral insulin sensitivity via multiple mechanisms
- Saturated fat excess: palmitate and certain saturated fatty acids directly impair insulin signalling in muscle and liver cells
Sources
- Matthews, D.R., et al. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419.
- Bonora, E., et al. (2000). Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care, 23(1), 57-63.
- Wallace, T.M., et al. (2004). Use and abuse of HOMA modeling. Diabetes Care, 27(6), 1487-1495.